Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1995 Aug;96(2):751–758. doi: 10.1172/JCI118119

Purification and partial sequencing of the major mitogen for human uterine smooth muscle-like cells in leiomyoma extracts.

A Sourla 1, M Koutsilieris 1
PMCID: PMC185259  PMID: 7635968

Abstract

We purified the major mitogen for human smooth muscle-like cells in leiomyoma extracts by sequential liquid chromatography on (a) carboxymethyl-Sepharose, (b) heparin-Sepharose columns, (c) cartridges of C18 silica, and (d) linear gradient reverse-phase high performance liquid chromatography. The mitogenic activity of the leiomyoma extract throughout purification was tested by tritiated thymidine incorporation and DNA content in NIH/3T3 fibroblasts and KW human smooth muscle-like cells. Purification of the leiomyoma-derived growth factor (LDGF) for KW smooth muscle-like cells confirmed that its partial NH2-terminal amino acid (aa) sequence (1-20 aa) was identical to 113-132 aa of the human cysteine-rich protein (hCRP). A synthetic peptide which was engineered based on the purified aa sequence, stimulated the proliferation and growth of KW cells. An oligonucleotide probe constructed by the cDNA of the hcrp gene that encodes this aa sequence depicted the expression of 1.9-kb LDGF mRNA in leiomyomas and myometrium. The expression of the LDGF mRNA was three to sixfold higher in leiomyomas compared with adjacent myometrium of women harboring leiomyomas by in situ hybridization analysis. These data suggest that LDGF may participate in the pathophysiology of uterine leiomyomas.

Full text

PDF
751

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beck C. A., Garner C. W. Characterization and estrogen regulation of growth factor activity from uterus. Mol Cell Endocrinol. 1989 May;63(1-2):93–101. doi: 10.1016/0303-7207(89)90085-3. [DOI] [PubMed] [Google Scholar]
  2. Beck C. A., Garner C. W. Characterization and estrogen regulation of growth factor activity from uterus. Mol Cell Endocrinol. 1989 May;63(1-2):93–101. doi: 10.1016/0303-7207(89)90085-3. [DOI] [PubMed] [Google Scholar]
  3. Birkenmeier E. H., Gordon J. I. Developmental regulation of a gene that encodes a cysteine-rich intestinal protein and maps near the murine immunoglobulin heavy chain locus. Proc Natl Acad Sci U S A. 1986 Apr;83(8):2516–2520. doi: 10.1073/pnas.83.8.2516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Biro J. C. Estrogen-induced proteins: a new class of regulatory substances. Med Hypotheses. 1986 Mar;19(3):199–228. doi: 10.1016/0306-9877(86)90069-1. [DOI] [PubMed] [Google Scholar]
  5. Boehm K. D., Daimon M., Gorodeski I. G., Sheean L. A., Utian W. H., Ilan J. Expression of the insulin-like and platelet-derived growth factor genes in human uterine tissues. Mol Reprod Dev. 1990 Oct;27(2):93–101. doi: 10.1002/mrd.1080270203. [DOI] [PubMed] [Google Scholar]
  6. Boehm T., Foroni L., Kennedy M., Rabbitts T. H. The rhombotin gene belongs to a class of transcriptional regulators with a potential novel protein dimerisation motif. Oncogene. 1990 Jul;5(7):1103–1105. [PubMed] [Google Scholar]
  7. Brigstock D. R., Heap R. B., Barker P. J., Brown K. D. Purification and characterization of heparin-binding growth factors from porcine uterus. Biochem J. 1990 Feb 15;266(1):273–282. doi: 10.1042/bj2660273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chegini N., Rao C. V., Wakim N., Sanfilippo J. Binding of 125I-epidermal growth factor in human uterus. Cell Tissue Res. 1986;246(3):543–548. doi: 10.1007/BF00215194. [DOI] [PubMed] [Google Scholar]
  9. Das S. K., Flanders K. C., Andrews G. K., Dey S. K. Expression of transforming growth factor-beta isoforms (beta 2 and beta 3) in the mouse uterus: analysis of the periimplantation period and effects of ovarian steroids. Endocrinology. 1992 Jun;130(6):3459–3466. doi: 10.1210/endo.130.6.1375903. [DOI] [PubMed] [Google Scholar]
  10. Fayed Y. M., Tsibris J. C., Langenberg P. W., Robertson A. L., Jr Human uterine leiomyoma cells: binding and growth responses to epidermal growth factor, platelet-derived growth factor, and insulin. Lab Invest. 1989 Jan;60(1):30–37. [PubMed] [Google Scholar]
  11. Ghahary A., Murphy L. J. Uterine insulin-like growth factor-I receptors: regulation by estrogen and variation throughout the estrous cycle. Endocrinology. 1989 Aug;125(2):597–604. doi: 10.1210/endo-125-2-597. [DOI] [PubMed] [Google Scholar]
  12. Huynh H. T., Pollak M. Insulin-like growth factor I gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182780. Cancer Res. 1993 Dec 1;53(23):5585–5588. [PubMed] [Google Scholar]
  13. Höppener J. W., Mosselman S., Roholl P. J., Lambrechts C., Slebos R. J., de Pagter-Holthuizen P., Lips C. J., Jansz H. S., Sussenbach J. S. Expression of insulin-like growth factor-I and -II genes in human smooth muscle tumours. EMBO J. 1988 May;7(5):1379–1385. doi: 10.1002/j.1460-2075.1988.tb02954.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Koutsilieris M., Elmeliani D., Frenette G., Maheux R. Leiomyoma-derived growth factors for smooth muscle cells. In Vivo. 1992 Nov-Dec;6(6):579–585. [PubMed] [Google Scholar]
  15. Koutsilieris M., Grondin F., Lehoux J. G. The expression of mRNA for glucocorticoid receptor gene and functional glucocorticoid receptors detected in PA-III rat prostate adenocarcinoma cells. Anticancer Res. 1992 May-Jun;12(3):899–904. [PubMed] [Google Scholar]
  16. Koutsilieris M. Human uterus-derived growth substances for rat bone cells and fibroblasts. Am J Obstet Gynecol. 1989 Nov;161(5):1313–1317. doi: 10.1016/0002-9378(89)90689-3. [DOI] [PubMed] [Google Scholar]
  17. Koutsilieris M., Michaud J. Characterization of human uterus-derived growth substances. In Vivo. 1990 May-Jun;4(3):161–165. [PubMed] [Google Scholar]
  18. Koutsilieris M., Michaud J., Nikolis A. Preferential mitogenic activity for myoblast-like cells can be extracted from uterine leiomyoma tissues. Am J Obstet Gynecol. 1990 Nov;163(5 Pt 1):1665–1670. doi: 10.1016/0002-9378(90)90647-p. [DOI] [PubMed] [Google Scholar]
  19. Koutsilieris M. Pathophysiology of uterine leiomyomas. Biochem Cell Biol. 1992 May;70(5):273–278. doi: 10.1139/o92-043. [DOI] [PubMed] [Google Scholar]
  20. Koutsilieris M., Rabbani S. A., Bennett H. P., Goltzman D. Characteristics of prostate-derived growth factors for cells of the osteoblast phenotype. J Clin Invest. 1987 Oct;80(4):941–946. doi: 10.1172/JCI113186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Koutsilieris M., Rabbani S. A., Goltzman D. Selective osteoblast mitogens can be extracted from prostatic tissue. Prostate. 1986;9(2):109–115. doi: 10.1002/pros.2990090202. [DOI] [PubMed] [Google Scholar]
  22. Koutsilieris M. Uterus-derived growth substances: possible implications for human uterus physiology and pathophysiology (review). The Group for Gynecological Investigation. In Vivo. 1990 Jan-Feb;4(1):45–48. [PubMed] [Google Scholar]
  23. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  24. Lazure C., Saayman H. S., Naudé R. J., Oelofsen W., Chrétien M. Ostrich MSEL-neurophysin belongs to the class of two-domain "big" neurophysin as indicated by complete amino acid sequence of the neurophysin/copeptin. Int J Pept Protein Res. 1989 Jan;33(1):46–58. doi: 10.1111/j.1399-3011.1989.tb00682.x. [DOI] [PubMed] [Google Scholar]
  25. Liebhaber S. A., Emery J. G., Urbanek M., Wang X. K., Cooke N. E. Characterization of a human cDNA encoding a widely expressed and highly conserved cysteine-rich protein with an unusual zinc-finger motif. Nucleic Acids Res. 1990 Jul 11;18(13):3871–3879. doi: 10.1093/nar/18.13.3871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lumsden M. A., West C. P., Bramley T., Rumgay L., Baird D. T. The binding of epidermal growth factor to the human uterus and leiomyomata in women rendered hypo-oestrogenic by continuous administration of an LHRH agonist. Br J Obstet Gynaecol. 1988 Dec;95(12):1299–1304. doi: 10.1111/j.1471-0528.1988.tb06821.x. [DOI] [PubMed] [Google Scholar]
  27. Maharajan P., Paino G., Rosato F., Mirabella N., Pelagalli G., Maharajan V. Influence of mouse uterus on the metastatic patterns of tumour cells. Cancer Lett. 1988 Dec 1;43(1-2):33–36. doi: 10.1016/0304-3835(88)90209-1. [DOI] [PubMed] [Google Scholar]
  28. Matsuo O., Fukao H., Izaki S., Matsuo C., Ueshima S. Production and characterization of single-chain tissue-type plasminogen activator produced by an established cell line from human uterine muscle. Cell Struct Funct. 1989 Feb;14(1):45–60. doi: 10.1247/csf.14.45. [DOI] [PubMed] [Google Scholar]
  29. Milner P. G., Li Y. S., Hoffman R. M., Kodner C. M., Siegel N. R., Deuel T. F. A novel 17 kD heparin-binding growth factor (HBGF-8) in bovine uterus: purification and N-terminal amino acid sequence. Biochem Biophys Res Commun. 1989 Dec 29;165(3):1096–1103. doi: 10.1016/0006-291x(89)92715-0. [DOI] [PubMed] [Google Scholar]
  30. Nalik P., Panayotova-Heiermann M., Pongs O. Characterization of an estradiol-stimulated mRNA in the brain of adult male rats. Mol Cell Endocrinol. 1989 Apr;62(2):235–242. doi: 10.1016/0303-7207(89)90010-5. [DOI] [PubMed] [Google Scholar]
  31. Pantazis C. G., Howard E. F. Metastasis-stimulating activity in the mouse uterus. Biol Reprod. 1987 Apr;36(3):701–708. doi: 10.1095/biolreprod36.3.701. [DOI] [PubMed] [Google Scholar]
  32. Pollard J. W. Regulation of polypeptide growth factor synthesis and growth factor-related gene expression in the rat and mouse uterus before and after implantation. J Reprod Fertil. 1990 Mar;88(2):721–731. doi: 10.1530/jrf.0.0880721. [DOI] [PubMed] [Google Scholar]
  33. Rein M. S., Friedman A. J., Pandian M. R., Heffner L. J. The secretion of insulin-like growth factors I and II by explant cultures of fibroids and myometrium from women treated with a gonadotropin-releasing hormone agonist. Obstet Gynecol. 1990 Sep;76(3 Pt 1):388–394. [PubMed] [Google Scholar]
  34. Rossi M. J., Chegini N., Masterson B. J. Presence of epidermal growth factor, platelet-derived growth factor, and their receptors in human myometrial tissue and smooth muscle cells: their action in smooth muscle cells in vitro. Endocrinology. 1992 Mar;130(3):1716–1727. doi: 10.1210/endo.130.3.1311246. [DOI] [PubMed] [Google Scholar]
  35. Simmen R. C., Ko Y., Liu X. H., Wilde M. H., Pope W. F., Simmen F. A. A uterine cell mitogen distinct from epidermal growth factor in porcine uterine luminal fluids: characterization and partial purification. Biol Reprod. 1988 Apr;38(3):551–561. doi: 10.1095/biolreprod38.3.551. [DOI] [PubMed] [Google Scholar]
  36. Sirbasku D. A. Estrogen induction of growth factors specific for hormone-responsive mammary, pituitary, and kidney tumor cells. Proc Natl Acad Sci U S A. 1978 Aug;75(8):3786–3790. doi: 10.1073/pnas.75.8.3786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Tommola P., Pekonen F., Rutanen E. M. Binding of epidermal growth factor and insulin-like growth factor I in human myometrium and leiomyomata. Obstet Gynecol. 1989 Oct;74(4):658–662. [PubMed] [Google Scholar]
  38. Vollenhoven B. J., Herington A. C., Healy D. L. Messenger ribonucleic acid expression of the insulin-like growth factors and their binding proteins in uterine fibroids and myometrium. J Clin Endocrinol Metab. 1993 May;76(5):1106–1110. doi: 10.1210/jcem.76.5.7684390. [DOI] [PubMed] [Google Scholar]
  39. Wang X., Lee G., Liebhaber S. A., Cooke N. E. Human cysteine-rich protein. A member of the LIM/double-finger family displaying coordinate serum induction with c-myc. J Biol Chem. 1992 May 5;267(13):9176–9184. [PubMed] [Google Scholar]
  40. Wordinger R. J., Moss A. E., Lockard T., Gray D., Chang I. F., Jackson T. L. Immunohistochemical localization of basic fibroblast growth factor within the mouse uterus. J Reprod Fertil. 1992 Sep;96(1):141–152. doi: 10.1530/jrf.0.0960141. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES